Company / CapEx per Share
CHINA PHARMA HOLDINGS, INC. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.00 / $0.08
FY2021-FY2025
Trend
+1578.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +1578% YoY in FY2025, a notable deviation from the 9-year average annual change of +273%.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of +42.3%.
Improved from $0.01 to $0.02 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -40.2%
- 5-Year CAGR
- +42.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 1578.0% year-over-year.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +1578.0% |
| FY2024 | $0.00 | -85.9% |
| FY2023 | $0.01 | -90.9% |
| FY2022 | $0.08 | +346.2% |
| FY2021 | $0.02 | +509.7% |
| FY2020 | $0.00 | +165.9% |
| FY2019 | $0.00 | -62.5% |
| FY2018 | $0.00 | -29.4% |
| FY2017 | $0.00 | +128.2% |
| FY2016 | -$0.02 | -113.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026